Figure 1From: Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial Patient allocation, follow-up, and analysis in the study of pelubiprofen versus celecoxib for the patients with rheumatoid arthritis. aExcluded from safety analysis. a+bExcluded from intention to treat analysis.Back to article page